Cargando…

Testosterone replacement therapy and the risk of prostate cancer

Understanding the role of testosterone replacement therapy (TRT) in the development and progression of prostate cancer is an important concept in treating patients with symptoms of hypogonadism. This article revealed a small number of mostly retrospective, observational studies describing the use of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warburton, Daniel, Hobaugh, Christopher, Wang, Grace, Lin, Haocheng, Wang, Run
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Invited Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814970/ https://www.ncbi.nlm.nih.gov/pubmed/25865848 http://dx.doi.org/10.4103/1008-682X.150841

Ejemplares similares

Effect of testosterone replacement treatment on constitutional and sexual symptoms in type 2 diabetic men: need for rules
por: Dimitriadis, Fotios, et al.
Publicado: (2015)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)

Alternatives to testosterone replacement: testosterone restoration
por: McCullough, Andrew
Publicado: (2015)

The multiple actions of testosterone in men: nature knows best
por: Funder, John W
Publicado: (2014)

The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2020)

Testosterone treatment in older men: glass half empty or half full?
por: Nolan, Brendan J, et al.
Publicado: (2017)

Testosterone replacement therapy: dilemmas and challenges in China and Asia
por: An, Qi, et al.
Publicado: (2018)

Reappraisal of glucocorticoids in castrate-resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2014)

Robotic radical prostatectomy in high-risk prostate cancer: current perspectives
por: Canda, Abdullah Erdem, et al.
Publicado: (2015)

Next generation patient-derived prostate cancer xenograft models
por: Lin, Dong, et al.
Publicado: (2014)

Does tadalafil prevent erectile dysfunction in patients undergoing radiation therapy for prostate cancer?
por: Incrocci, Luca
Publicado: (2014)

New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones
por: Schally, Andrew V, et al.
Publicado: (2015)

Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib
por: Beltran, Himisha, et al.
Publicado: (2014)

Prostate cancer screening: and yet it moves!
por: Kwiatkowski, Maciej, et al.
Publicado: (2015)

To screen or not to screen: the prostate cancer dilemma
por: Stone, Nelson N, et al.
Publicado: (2015)

Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identification
por: Chiang, Yan Ting, et al.
Publicado: (2014)

Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment
por: Lv, Jialu, et al.
Publicado: (2020)

External beam radiotherapy for localized prostate cancer
por: Yilmaz, Hasan, et al.
Publicado: (2015)

Current and emerging trends in prostate cancer immunotherapy
por: Schatz, Adam, et al.
Publicado: (2019)

Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations
por: Morgentaler, Abraham, et al.
Publicado: (2015)

Androgen receptor functions in prostate cancer development and progression
por: Balk, Steven P
Publicado: (2014)

Prevention of erectile dysfunction after radiotherapy for prostate cancer
por: Faiena, Izak, et al.
Publicado: (2014)

Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use
por: McBride, J Abram, et al.
Publicado: (2016)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Transcriptome sequencing in prostate cancer identifies inter-tumor heterogeneity
por: Mendonca, Janet, et al.
Publicado: (2015)

Long-term survival of participants in the prostate cancer prevention trial
por: Silberstein, Jonathan L, et al.
Publicado: (2014)

Management of localized prostate cancer: the pendulum swings (back to the middle)
por: Vuong, Winston, et al.
Publicado: (2014)

Lipogenic metabolism: a viable target for prostate cancer treatment?
por: Liang, Mengmeng, et al.
Publicado: (2014)

HOXB13 and other high penetrant genes for prostate cancer
por: Pilie, Patrick G, et al.
Publicado: (2016)

Highlight on Engineering Mycobacterium smegmatis for testosterone production
por: Sood, Utkarsh, et al.
Publicado: (2016)

Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods
por: Moyad, Mark A
Publicado: (2015)

What is the next generation therapeutic strategy for castration-resistant prostate cancer
por: Wen, Si-Meng, et al.
Publicado: (2015)

Re: Long-term survival of participants in the Prostate Cancer Prevention Trial
por: Thompson, Ian M, et al.
Publicado: (2014)

Long noncoding RNA-mediated activation of androgen receptor in prostate cancer
por: Petrovics, Gyorgy, et al.
Publicado: (2014)

Tools to identify the men with prostate cancer most appropriate for active surveillance?
por: Getzenberg, Robert H
Publicado: (2014)

Use of early chemotherapy for hormone-sensitive prostate cancer: time for CHAARTED
por: Aragon-Ching, Jeanny B
Publicado: (2016)

The promising role of poly(ADP-ribose) polymerase inhibitors in prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2016)

Who are the fair candidates for testosterone replacement therapy in patients with late-onset hypogonadism symptoms?
por: Amano, Toshiyasu
Publicado: (2023)

Relapse of prostate cancer from the viewpoint of total gland volume kinetics theory
por: Watanabe, Hiroki
Publicado: (2015)

Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
por: Yamada, Yasuhiro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mv63kpbt6k9csna56l34nmrhoe